Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | HTT | P42858 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | CTSK | P43235 | 6/20 | 0.40 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.40 |
| ▸ | PLG | P00747 | 1/20 | 0.40 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.40 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.39 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.39 |
| ▸ | CTSS | P25774 | 3/20 | 0.39 |
| ▸ | CTSL | P07711 | 1/20 | 0.39 |
| ▸ | TGM2 | P21980 | 1/20 | 0.39 |
| ▸ | MEN1 | O00255 | 1/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18885737 | 0.89 | LMNA (0.44) | SMN1; SMN2LMNAHTTL3MBTL1MAPT | |
| SCHEMBL19001575 | 0.86 | CTSK (0.44) | SMN1; SMN2LMNAHTTL3MBTL1MAPT | |
| SCHEMBL17232558 | 0.85 | SMN1; SMN2 (0.49) | SMN1; SMN2LMNAHTTL3MBTL1MAPT | |
| SCHEMBL19750475 | 0.84 | LMNA (0.63) | SMN1; SMN2LMNAHTTL3MBTL1MAPT | |
| SCHEMBL19154486 | 0.84 | SMN1; SMN2 (0.48) | SMN1; SMN2LMNAHTTL3MBTL1MAPT | |
| SCHEMBL24270701 | 0.82 | LMNA (0.50) | SMN1; SMN2LMNAHTTL3MBTL1MAPT | |
| SCHEMBL17448403 | 0.81 | SMN1; SMN2 (0.48) | SMN1; SMN2LMNAHTTL3MBTL1MAPT | |
| SCHEMBL24760536 | 0.81 | ALDH1A1 (0.44) | SMN1; SMN2LMNAL3MBTL1CTSKTPSAB1 | |
| SCHEMBL21788083 | 0.81 | TOP2A (0.51) | SMN1; SMN2LMNAL3MBTL1CTSKTPSAB1 | |
| SCHEMBL22154185 | 0.80 | SMN1; SMN2 (0.54) | SMN1; SMN2LMNAHTTL3MBTL1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | HANGZHOU DAC BIOTECH CO., LTD. (CN) | 2021-10-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210308277-A1 | CONJUGATION LINKERS, CELL BINDING MOLECULE-DRUG CONJUGATES CONTAINING THE LINKERS, METHODS OF MAKING AND USES SUCH CONJUGATES WITH THE LINKERS | CD2BP2, DCLRE1A, EPCAM | SMN1; SMN2 4501/4885LMNA 1970/4885HTT 3736/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.